This observation extends to other cancer types too, for example non-Hodgkin lymphoma [201], germinal centre B-cell lymphoma [202], and acute lymphoblastic leukaemia [203,204] where concurrent activation of BCL-2 and MYC occurred leading to their elevated levels. Here, BCL2 is linked to acute lymphoblastic leukemia.